Study Warns of Alzheimer’s Risk in Some Prostate-Cancer Drugs

Men taking testosterone-blocking drugs have nearly twice the risk of developing disease as those using other treatments.

Men taking testosterone-blocking drugs to treat prostate cancer have nearly twice the risk of developing Alzheimer’s disease as those using other treatments, according to an analysis of electronic medical records published Monday.

Source: THE WALL STREET JOURNAL